Physician

Malvin Yan, D.O.

According to 2025 Medicare claims, Malvin Yan, D.O. (NPI: 1033153101) practices nephrology in the Los Angeles-Long Beach-Glendale, CA market, with the plurality of this provider's patient population coming from Los Angeles, CA. This provider's primary affiliated billing organization is DR MALVIN YAN INC (NPI: 1225146061; TIN: 900272142) and primary practice location at 90723-3644.

Yan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 586 traditional Medicare patients, billed 7,268 HCPCS/CPT codes, and received $1,192,828 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 10,954 prescription claims across 539 beneficiaries totaling $1,151,857 in drug costs, led by Eliquis (Apixaban). DME data shows 606 claims. Open Payments data shows 279 records totaling $555,596. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $1,003,771 and ending at $1,151,857. In contrast, DME billing represents a smaller volume and rose steadily, from $7,635 to $82,474.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	600	7,018	$744,522
2016	657	7,507	$750,048
2017	724	8,363	$813,110
2018	684	8,012	$803,334
2019	668	8,487	$854,582
2020	655	8,881	$926,318
2021	550	7,221	$738,387
2022	579	6,702	$608,066
2023	522	6,023	$564,109
2024	586	7,268	$1,192,828

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	386	10,701	$1,003,771
2016	437	11,009	$1,238,489
2017	455	11,680	$1,617,662
2018	498	12,119	$1,053,103
2019	531	11,021	$814,233
2020	625	9,389	$795,021
2021	601	11,504	$1,616,781
2022	623	10,652	$1,690,912
2023	561	11,085	$2,338,597
2024	539	10,954	$1,151,857

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	37	190	$5,944
2016	35	196	$5,749
2017	61	308	$9,422
2018	48	266	$24,029
2019	56	388	$49,858
2020	13	421	$28,512
2021	50	501	$34,290
2022	94	639	$25,961
2023	107	539	$30,518
2024	34	606	$47,578

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	374	508	$142
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	98	335	$107
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	127	953	$97
99309	Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes	114	608	$89
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	378	3,509	$65

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	265	4,560	$91,563
Jardiance	Empagliflozin	91	3,920	$72,291
Farxiga	Dapagliflozin Propanediol	55	3,360	$58,443
Trulicity	Dulaglutide	32	1,232	$41,883
Kerendia	Finerenone	37	1,830	$38,389

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A6010	Collagen based wound filler, dry form, sterile, per gram of collagen	N	N/R	12	$11,331
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	33	$9,937
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	62	$4,401
A6196	Alginate or other fiber gelling dressing, wound cover, sterile, pad size 16 sq. in. or less, each dressing	N	N/R	14	$3,542
B4035	Enteral feeding supply kit; pump fed, per day, includes but not limited to feeding/flushing syringe, administration set tubing, dressings, tape	N	N/R	26	$3,262

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	40	$935	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	239	$554,662	AstraZeneca Pharmaceuticals LP
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Malvin Yan, D.O.?

Tedicare shows public-source Medicare data for Malvin Yan, D.O. (NPI 1033153101), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Malvin Yan, D.O. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Malvin Yan, D.O.?

Malvin Yan, D.O. is linked to DR MALVIN YAN INC (billing NPI 1225146061) in the available physician profile data.

Does Malvin Yan, D.O. have Open Payments data?

Malvin Yan, D.O. has 279 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.